Stay updated on Remdesivir Efficacy in Severe COVID-19 Clinical Trial
Sign up to get notified when there's something new on the Remdesivir Efficacy in Severe COVID-19 Clinical Trial page.

Latest updates to the Remdesivir Efficacy in Severe COVID-19 Clinical Trial page
- Check7 days agoNo Change Detected
- Check14 days agoChange DetectedA new site revision label, Revision: v3.4.2, is now shown. The previous funding/operating status notice (Revision: v3.4.1) has been removed.SummaryDifference0.5%

- Check21 days agoChange DetectedA site-wide funding-status notice was added and the page version updated from v3.4.0 to v3.4.1; To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.5%

- Check28 days agoChange DetectedAdded: Show glossary option; Last Update Submitted that Met QC Criteria; No FEAR Act Data; Revision: v3.4.0. Removed/altered: Last Update Submitted that met QC Criteria; No FEAR Act data; Revision: v3.3.4.SummaryDifference0.2%

- Check43 days agoChange DetectedThe page shows Revision: v3.3.4 where previously v3.3.3 appeared.SummaryDifference0.1%

- Check64 days agoChange DetectedAdded a dedicated Locations section featuring Beijing Municipality as a location. The previous 'Beijing Municipality Locations' entry was removed.SummaryDifference0.2%

- Check92 days agoChange DetectedThese updates are minor editorial notes about how PubMed publications are displayed and include a page revision tag; they do not affect core study details. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

Stay in the know with updates to Remdesivir Efficacy in Severe COVID-19 Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Remdesivir Efficacy in Severe COVID-19 Clinical Trial page.